Skip to main content
Erschienen in: Notfall + Rettungsmedizin 2/2022

08.12.2022 | Originalien

Comparison of ibuprofen and dexketoprofen in the management of migraine-related headache in the emergency department

verfasst von: Sedanur Şafak, Şeref Kerem Çorbacioğlu, Osman Korucu, Emine Emektar, Yunsur Çevik

Erschienen in: Notfall + Rettungsmedizin | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this randomized controlled study was to compare the efficacy and safety of intravenous (IV) ibuprofen with IV dexketoprofen trometamol in patients with migraine attack-related headaches and receiving IV metoclopramide as part of their standard care.

Methods

This double-blinded and randomized controlled study was conducted among patients with acute migraine-related headaches admitted to the emergency department (ED). Eligible patients were randomly assigned in a 1:1 ratio to receive ibuprofen or dexketoprofen trometamol. In addition, all participants received 10 mg of IV metoclopramide. All patients’ headache scores were measured with a visual analog scale (VAS); 0 points was considered no pain, while 100 points were considered worst pain. The primary outcome was defined as the absolute change in the headache scores between the groups at 0 and 60 min.

Results

A total of 160 patients were randomized into two groups with similar baseline migraine characteristics and VAS scores. In each group, the baseline VAS scores significantly decreased statistically over time. However, when the decreasing trends of VAS values were compared according to the treatment groups, a statistically significant difference was found in the VAS values at 30 min, but no difference was found for the 60 min VAS values. There was no statistically significant difference in the need for rescue treatment and side effects between the two groups.

Conclusion

Intravenous ibuprofen and dexketoprofen trometamol treatments are equal to each other in terms of efficacy, side effects, and need for rescue treatment in the management of acute migraine-related headaches.
Literatur
2.
Zurück zum Zitat Burch RC, Loder S, Loder E, Smitherman TA (2015) The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 55:21–34CrossRef Burch RC, Loder S, Loder E, Smitherman TA (2015) The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 55:21–34CrossRef
3.
Zurück zum Zitat Cameron C, Kelly S, Hsieh SC et al (2015) Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 55(Suppl 4):221–235CrossRef Cameron C, Kelly S, Hsieh SC et al (2015) Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 55(Suppl 4):221–235CrossRef
5.
Zurück zum Zitat Kirthi V, Derry S, Moore RA (2013) Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD8041 Kirthi V, Derry S, Moore RA (2013) Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD8041
6.
Zurück zum Zitat Derry S, Moore RA (2013) Paracetamol (Acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD8040 Derry S, Moore RA (2013) Paracetamol (Acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD8040
7.
Zurück zum Zitat Amini-Parikhani M, Ghaffarazad A, Soleimanpour H, Ebrahimi-Bakhtavar H, Rahmani F (2020) Efficacy of adding Midazolam to Paracetamol in pain control of patients with a primary headache: A randomized, clinical trial study. Turk J Emerg Med 20(2):63–68. https://doi.org/10.4103/2452-2473.285011CrossRef Amini-Parikhani M, Ghaffarazad A, Soleimanpour H, Ebrahimi-Bakhtavar H, Rahmani F (2020) Efficacy of adding Midazolam to Paracetamol in pain control of patients with a primary headache: A randomized, clinical trial study. Turk J Emerg Med 20(2):63–68. https://​doi.​org/​10.​4103/​2452-2473.​285011CrossRef
8.
Zurück zum Zitat Goldstein J, Hagen M, Gold M (2014) Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of Acetaminophen, acetylsalicylic acid, and caffeine with Ibuprofen for acute treatment of patients with severe migraine. Cephalalgia 34(13):1070–1078. https://doi.org/10.1177/0333102414530527CrossRef Goldstein J, Hagen M, Gold M (2014) Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of Acetaminophen, acetylsalicylic acid, and caffeine with Ibuprofen for acute treatment of patients with severe migraine. Cephalalgia 34(13):1070–1078. https://​doi.​org/​10.​1177/​0333102414530527​CrossRef
9.
Zurück zum Zitat Law S, Derry S, Moore RA (2013) Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 10:CD9455 Law S, Derry S, Moore RA (2013) Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 10:CD9455
10.
11.
14.
Zurück zum Zitat Oncel G, Yilmaz A, Sabirli R, Cimen YK, Ozen M, Seyit M, Turkcuer I, Cimen U (2021) Comparative evaluation of the efficacy of intravenous Paracetamol and Ibuprofen on the treatment of tonsillopharyngitis with fever: A prospective, randomized controlled, double-blind clinical trial. Turk J Emerg Med 21(4):177–183. https://doi.org/10.4103/2452-2473.329629CrossRef Oncel G, Yilmaz A, Sabirli R, Cimen YK, Ozen M, Seyit M, Turkcuer I, Cimen U (2021) Comparative evaluation of the efficacy of intravenous Paracetamol and Ibuprofen on the treatment of tonsillopharyngitis with fever: A prospective, randomized controlled, double-blind clinical trial. Turk J Emerg Med 21(4):177–183. https://​doi.​org/​10.​4103/​2452-2473.​329629CrossRef
17.
Zurück zum Zitat Safaie A, Tavoli M, Babaniamansour S, Aliniagerdroudbari E, Mousavi A, Sotoodehnia M, Bahreini M (2022) Intravenous morphine plus Ibuprofen or Ketorolac versus intravenous morphine alone in reducing renal colic pain intensity in emergency department: A randomized, double-blind clinical trial. Turk J Emerg Med 22(1):8–14. https://doi.org/10.4103/2452-2473.336108CrossRef Safaie A, Tavoli M, Babaniamansour S, Aliniagerdroudbari E, Mousavi A, Sotoodehnia M, Bahreini M (2022) Intravenous morphine plus Ibuprofen or Ketorolac versus intravenous morphine alone in reducing renal colic pain intensity in emergency department: A randomized, double-blind clinical trial. Turk J Emerg Med 22(1):8–14. https://​doi.​org/​10.​4103/​2452-2473.​336108CrossRef
19.
Zurück zum Zitat Todd KH, Funk JP (1996) The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 3:142–146CrossRef Todd KH, Funk JP (1996) The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 3:142–146CrossRef
20.
Zurück zum Zitat Friedman B, Garber L, Yoon A et al (2014) Randomized trial of IV Valproate vs Metoclopramide vs Ketorolac for acute migraine. Neurology 82:976–983CrossRef Friedman B, Garber L, Yoon A et al (2014) Randomized trial of IV Valproate vs Metoclopramide vs Ketorolac for acute migraine. Neurology 82:976–983CrossRef
21.
Zurück zum Zitat Bonett DG, Price RM (2002) Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychol Methods 7:370–383CrossRef Bonett DG, Price RM (2002) Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychol Methods 7:370–383CrossRef
22.
Zurück zum Zitat Altman DG, Machin D, Bryant TN, Gardner MJ (eds) (2000) Statistics with confidence, 2nd edn. BMJ Books, London, p 49 Altman DG, Machin D, Bryant TN, Gardner MJ (eds) (2000) Statistics with confidence, 2nd edn. BMJ Books, London, p 49
25.
Zurück zum Zitat Yavuz E, Gulacti U, Lok U, Turgut K (2020) Intravenous Metoclopramide versus Dexketoprofen Trometamol versus Metoclopramide+ Dexketoprofen Trometamol in acute migraine attack in the emergency department: A randomized double-blind controlled trial. Am J Emerg Med 38(11):2254–2258. https://doi.org/10.1016/j.ajem.2020.04.038CrossRef Yavuz E, Gulacti U, Lok U, Turgut K (2020) Intravenous Metoclopramide versus Dexketoprofen Trometamol versus Metoclopramide+ Dexketoprofen Trometamol in acute migraine attack in the emergency department: A randomized double-blind controlled trial. Am J Emerg Med 38(11):2254–2258. https://​doi.​org/​10.​1016/​j.​ajem.​2020.​04.​038CrossRef
Metadaten
Titel
Comparison of ibuprofen and dexketoprofen in the management of migraine-related headache in the emergency department
verfasst von
Sedanur Şafak
Şeref Kerem Çorbacioğlu
Osman Korucu
Emine Emektar
Yunsur Çevik
Publikationsdatum
08.12.2022
Verlag
Springer Medizin
Erschienen in
Notfall + Rettungsmedizin / Ausgabe Sonderheft 2/2022
Print ISSN: 1434-6222
Elektronische ISSN: 1436-0578
DOI
https://doi.org/10.1007/s10049-022-01105-w

Weitere Artikel der Sonderheft 2/2022

Notfall + Rettungsmedizin 2/2022 Zur Ausgabe